Customized Chemotherapy Did Not Improve Survival in Early NSCLC ...Middle East

Medscape - News
Tailoring adjuvant chemotherapy based on the expression of two molecular markers did not confer a survival advantage in patients with completely resected stage 2-3 NSCLC in a phase 3 trial. Medscape Medical News

Hence then, the article about customized chemotherapy did not improve survival in early nsclc was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Customized Chemotherapy Did Not Improve Survival in Early NSCLC )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News